Jean Terrier
9PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 04, 2025
Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban.Frédéric Gaspar, Jean Terrier, Celestin Jacot-Descombes
|Jan 11, 2025
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling.Frédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin
|Nov 13, 2024
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.Jean Terrier, Kenza Abouir, Frederic Gaspar
|Oct 05, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.Jean Terrier, Frédéric Gaspar, Pauline Gosselin
|Sep 19, 2023
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.Frédéric Gaspar, Jean Terrier, Samantha Favre
|Sep 09, 2022
CYP450 3A4/5 Containment During SARS-CoV-2 Infection.Jean Terrier, Camille Lenoir, Caroline Samer
Pageof 2
Frequent Collaborators
4 joint publications
Pierre Fontana
4 joint publications
Camille Lenoir
4 joint publications
Frédéric Gaspar
3 joint publications
Caroline Samer
2 joint publications
Jean-Luc Reny
1 joint publications
Marie-Céline Zanella
1 joint publications
Dionysios Neofytos
1 joint publications
Kenza Abouir
1 joint publications
Youssef Daali
1 joint publications
Victoria Rollason
